Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

BACKGROUND: With the promise of disease modifying treatments, there is a need for more specific diagnosis and prognosis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Plasma biomarkers are likely to be utilised to increase diagnostic accuracy and specificity of AD and cognitive dec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Song, Fei, Poljak, Anne, Kochan, Nicole A, Raftery, Mark, Brodaty, Henry, Smythe, George A, Sachdev, Perminder S
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2014
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3898732/ https://ncbi.nlm.nih.gov/pubmed/24433274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5956-12-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

Similar Items